Clene INC Schedule 13G passive stakes

Vivo Opportunity entities have reported beneficial ownership of 9.99% of Clene Inc.'s common stock, primarily through exercisable warrants.

Chidozie Ugwumba has reported a complete divestment of all beneficial ownership in Clene Inc., ceasing to have voting or investment power over the company's holdings.

Empery Asset Management, LP, through its managed funds, has acquired a beneficial ownership of 916,532 shares, representing 7.17% of Clene Inc.'s common stock, as of June 30, 2026.

Investor Chidozie Ugwumba has filed a Schedule 13G reporting a 9.7% beneficial ownership stake in Clene Inc. common stock.

Alison Mosca has filed an amended Schedule 13G reporting a 13% beneficial ownership stake in Clene Inc. common stock.

Chidozie Ugwumba has filed an amendment to his Schedule 13G, reporting beneficial ownership of 1,915,650 shares of Clene Inc. common stock.

Vivo Opportunity Fund Holdings and related entities have filed a Schedule 13G reporting a 9.99% beneficial ownership stake in Clene Inc.

AWM Investment Company, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 4.7% of Clene Inc.'s common stock.

David Lisonbee and 4Life Research, LLC have disclosed their beneficial ownership in Clene Inc., collectively holding 6.5% and 3.7% of the common stock, respectively, as of December 20, 2024.

Armistice Capital, LLC and Steven Boyd have filed an amended Schedule 13G, disclosing a beneficial ownership of 4.99% of CLENE INC.'s common stock as of December 31, 2024.

AWM Investment Company, Inc. has filed an amended Schedule 13G, reporting a 5.7% beneficial ownership stake in Clene Inc. as of December 31, 2024, primarily through warrants.

Alison Mosca has filed an Amendment No. 3 to Schedule 13G, disclosing a 19.7% beneficial ownership stake in Clene Inc. as of December 31, 2024, totaling 1,893,162 shares.